Hospital pricing fraud, insurance denials, pharmaceutical markups traced to CMS and HHS data.
Downloadable intelligence briefs with legislation drafts, cost analyses, and implementation roadmaps.
Data points pulled directly from federal databases and government records.
CMS data shows 73% of hospitals failed to comply with price transparency rules in 2025, hiding negotiated rates from patients.
HHS Inspector General identified $4.7 billion in improper Medicare Advantage payments in a single fiscal year.
FDA adverse event reports reveal 340% increase in pharmaceutical recall actions over the past decade while enforcement budgets decreased.
Have firsthand experience with healthcare fraud or failure? Your story helps build the case.